Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].

BACKGROUND: Standard coronary artery bypass graft surgery uses a single internal mammary artery and supplemental vein or radial artery grafts. Several observational studies have suggested a survival benefit with two internal mammary artery grafts compared to a single internal mammary artery graft, b...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Taggart, D, Lees, B, Gray, A, Altman, D, Flather, M, Channon, K
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 2006
_version_ 1826292957021470720
author Taggart, D
Lees, B
Gray, A
Altman, D
Flather, M
Channon, K
author_facet Taggart, D
Lees, B
Gray, A
Altman, D
Flather, M
Channon, K
author_sort Taggart, D
collection OXFORD
description BACKGROUND: Standard coronary artery bypass graft surgery uses a single internal mammary artery and supplemental vein or radial artery grafts. Several observational studies have suggested a survival benefit with two internal mammary artery grafts compared to a single internal mammary artery graft, but this has not been tested in a randomised trial. The Arterial Revascularisation Trial is a Medical Research Council and British Heart Foundation funded, multi-centre international trial comparing single internal mammary artery grafting versus bilateral internal mammary artery grafting. METHODS/DESIGN: Twenty centres in the UK, Australia, Poland and Brazil are planning to randomise 3000 coronary artery bypass graft surgery patients to single or bilateral internal mammary artery grafting. Supplemental grafts may be either saphenous vein or radial artery. Coronary artery bypass grafting can be performed as an on-pump or off-pump procedure. The primary outcome is survival at 10 years and secondary end-points include clinical events, quality of life and cost effectiveness. The effect of age, left ventricular function, diabetes, number of grafts, vein grafts and off-pump surgery are pre-specified subgroups. DISCUSSION: The Arterial Revascularisation Trial is one of the first randomised trials to evaluate the effects on survival and other clinical outcomes of single internal mammary artery grafting versus bilateral internal mammary artery grafting, and will help to establish the best approach for patients requiring coronary artery bypass graft surgery.
first_indexed 2024-03-07T03:22:41Z
format Journal article
id oxford-uuid:b7f891d8-7cb0-49b5-806e-e211d817aee5
institution University of Oxford
language English
last_indexed 2024-03-07T03:22:41Z
publishDate 2006
record_format dspace
spelling oxford-uuid:b7f891d8-7cb0-49b5-806e-e211d817aee52022-03-27T04:52:32ZProtocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b7f891d8-7cb0-49b5-806e-e211d817aee5EnglishSymplectic Elements at Oxford2006Taggart, DLees, BGray, AAltman, DFlather, MChannon, KBACKGROUND: Standard coronary artery bypass graft surgery uses a single internal mammary artery and supplemental vein or radial artery grafts. Several observational studies have suggested a survival benefit with two internal mammary artery grafts compared to a single internal mammary artery graft, but this has not been tested in a randomised trial. The Arterial Revascularisation Trial is a Medical Research Council and British Heart Foundation funded, multi-centre international trial comparing single internal mammary artery grafting versus bilateral internal mammary artery grafting. METHODS/DESIGN: Twenty centres in the UK, Australia, Poland and Brazil are planning to randomise 3000 coronary artery bypass graft surgery patients to single or bilateral internal mammary artery grafting. Supplemental grafts may be either saphenous vein or radial artery. Coronary artery bypass grafting can be performed as an on-pump or off-pump procedure. The primary outcome is survival at 10 years and secondary end-points include clinical events, quality of life and cost effectiveness. The effect of age, left ventricular function, diabetes, number of grafts, vein grafts and off-pump surgery are pre-specified subgroups. DISCUSSION: The Arterial Revascularisation Trial is one of the first randomised trials to evaluate the effects on survival and other clinical outcomes of single internal mammary artery grafting versus bilateral internal mammary artery grafting, and will help to establish the best approach for patients requiring coronary artery bypass graft surgery.
spellingShingle Taggart, D
Lees, B
Gray, A
Altman, D
Flather, M
Channon, K
Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title_full Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title_fullStr Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title_full_unstemmed Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title_short Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
title_sort protocol for the arterial revascularisation trial art a randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation isrctn46552265
work_keys_str_mv AT taggartd protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265
AT leesb protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265
AT graya protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265
AT altmand protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265
AT flatherm protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265
AT channonk protocolforthearterialrevascularisationtrialartarandomisedtrialtocomparesurvivalfollowingbilateralversussingleinternalmammarygraftingincoronaryrevascularisationisrctn46552265